Literature DB >> 6361430

Antimicrobial prophylaxis for contaminated head and neck surgery.

J T Johnson, E N Myers, P B Thearle, B A Sigler, V L Schramm.   

Abstract

The use of antibiotic prophylaxis in head and neck surgery is controversial. Most surgeons agree that when surgery requires entry into the aerodigestive tract through the skin the wound is by definition contaminated and antibiotic prophylaxis is indicated as it is in other contaminated wounds. There is no general agreement as to which antibiotic or combination of antibiotics to use or what the schedule of dosage administration should be. In order to obtain a meaningful data to help in decision making, a double blind, randomized study was performed to investigate whether cefazolin alone or a combination of gentamicin and clindamycin was more effective in prophylaxis. All patients entered into the study underwent major oncologic head and neck surgery requiring entry into the upper aerodigestive tract through the skin. Patients were stratified at entry according to the stage of disease, surgical procedure, and the existence of a prior tracheotomy or prior radiation therapy. Subsequently, patients were randomly assigned to 1 of 4 treatment groups. Group I: Cefazolin 1 day, placebo day 2 to 5. Group II: Cefazolin days 1 to 5, Group III: Gentamicin and clindamycin 1 day, placebo days 2 to 5. Group IV: Gentamicin and clindamycin days 1 to 5. Drugs were given intravenously beginning 3 hours preoperatively and continued postoperatively every 8 hours, according to the assigned schedule. All wounds were observed daily following surgery and were graded on a predetermined scale by 3 unbiased observers. Significantly wound infections occurred in 15% of all patients. Group I, 33%; Group II, 20%; Group III, 7%; Group IV, 4%. In Group III and Group IV there was a statistically significant (P less than .05) reduction in the rate of postoperative wound infection. Multifactorial analysis demonstrated that patients whose surgery included repair with a regional pectoral flap had a statistically significant increased chance of developing postoperative wound infection (P less than .05). Patients undergoing laryngectomy, with or without neck dissection, were at less risk of postoperative infection tham patients undergoing oropharyngeal resection (P less than .05). The preoperative existence of tracheotomy or prior radiation therapy had no demonstrable effect on the incidence of wound infection postoperatively in this study.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6361430     DOI: 10.1002/lary.5540940111

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  26 in total

1.  Prevention and Treatment of Postsurgical Head and Neck Infections.

Authors:  Rebecca Fraioli; Jonas T. Johnson
Journal:  Curr Infect Dis Rep       Date:  2004-06       Impact factor: 3.725

2.  Post-operative wound infection in salvage laryngectomy: does antibiotic prophylaxis have an impact?

Authors:  William Scotton; Richard Cobb; Leo Pang; Iain Nixon; Anil Joshi; Jeanne-Pierre Jeannon; Richard Oakley; Gary French; Carolyn Hemsley; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-25       Impact factor: 2.503

3.  Risk factors of recipient site infection in head and neck cancer patients undergoing pectoralis major myocutaneous flap reconstruction.

Authors:  Chao-Hsien Wang; Yong-Kie Wong; Ching-Ping Wang; Chen-Chi Wang; Rong-San Jiang; Chih-Sheng Lai; Shih-An Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-31       Impact factor: 2.503

Review 4.  [Prophylactic antibiotic use in ENT surgery].

Authors:  C Thorn; A Faber; J D Schultz; K Hörmann; B A Stuck
Journal:  HNO       Date:  2015-02       Impact factor: 1.284

5.  Antimicrobial prophylaxis for major head and neck surgery in cancer patients.

Authors:  M Gerard; F Meunier; P Dor; G Andry; G Chantrain; P Van der Auwera; D Daneau; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

6.  Antibiotic use during major head and neck surgery.

Authors:  J T Johnson; V L Yu
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

7.  Reduction of oral flora with rifampin in healthy volunteers.

Authors:  P C Appelbaum; S K Spangler; C R Potter; F R Sattler
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

8.  Professional oral health care reduces the duration of hospital stay in patients undergoing orthognathic surgery.

Authors:  Hideo Shigeishi; Mohammad Zeshaan Rahman; Kouji Ohta; Shigehiro Ono; Masaru Sugiyama; Masaaki Takechi
Journal:  Biomed Rep       Date:  2015-11-10

Review 9.  Cephalosporins in surgery. Prophylaxis and therapy.

Authors:  D W McEniry; S L Gorbach
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 10.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.